Humedix Co., Ltd. (KOSDAQ:200670)
South Korea · Delayed Price · Currency is KRW 43,950
-300 (-0.68%)
At close: Dec 5, 2025
Humedix Market Cap
Humedix has a market cap or net worth of 453.57 billion as of December 5, 2025. Its market cap has increased by 47.16% in one year.
Market Cap
453.57B
Enterprise Value
n/a
Revenue
110.99B
Ranking
n/a
PE Ratio
45.59
Stock Price
43,950.00
Market Cap Chart
Since December 26, 2014, Humedix's market cap has increased from 223.01B to 453.57B, an increase of 103.39%. That is a compound annual growth rate of 6.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 453.57B | 4.14% |
| Dec 30, 2024 | 435.54B | 24.67% |
| Dec 28, 2023 | 349.36B | 38.28% |
| Dec 29, 2022 | 252.65B | 12.18% |
| Dec 30, 2021 | 225.21B | -0.11% |
| Dec 30, 2020 | 225.47B | 2.25% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 76.57T |
| Celltrion | 39.95T |
| ALTEOGEN | 27.76T |
| ABL Bio | 11.08T |
| SK Biopharmaceuticals | 10.61T |
| Yuhan | 8.91T |
| LigaChem Biosciences | 7.14T |
| Peptron | 6.67T |